The new lymphoma drug Polivy can be prescribed at the Big 5 General Hospital. According to related industries, Samsung Medical Center, Seoul National University Hospital, Seoul St. Mary's Hospital, Seoul National University Hospital, and Antibody-drug conjugate (ADC) Polivy, which combines with existing BR therapy (Bendamustine & Rituximab) for treatment of Diffuse Large B-Cell Lympoma (DLBCL) with a poor prognosis. In the case of Severance, the code was generated with emergency DC.

However, Polivy is still a non-reimbursed drug. Roche submitted an application for registration of Polivy's insurance benefits in February last year, but failed to pass the HIRA Cancer Disease Review Committee in April of th